HMHassan Maleki

Hassan Maleki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hassan Maleki has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Maryam Doostan

    Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

    11 shared publications
  • Mahtab Doostan

    Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

    6 shared publications
  • Kamyar Khoshnevisan

    Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1983963113, Iran

    5 shared publications
  • Kamyar Khoshnevisan

    Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    5 shared publications
  • Hadi Baharifar

    Department of Biomedical Engineering, SR.C., Islamic Azad University, Tehran, Iran

    4 shared publications
  • Mohammad Hosein Farzaei

    Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran

    3 shared publications

Latest Publications

  • Selenium nanoparticle-and quercetin-embedded nanofibrous mats for enhanced cutaneous wound healing

    by Hassan Maleki, Kamyar Khoshnevisan, Hadi Baharifar, Behrang Shiri Varnamkhasti, Ahsan Yousefi


  • Engineering a dual-layer hydrogel–nanofiber scaffold co-loaded with 5-FU and quercetin for enhanced melanoma cell inhibition

    by Bita Jahanshahi, Shirin Shojaei, Maryam Doostan, Kamyar Khoshnevisan, Hadi Baharifar, Hassan Maleki

  • Nanoemulsion-Mediated Delivery of Silymarin to Boost Anticancer Potential against Colorectal Cancer

    by Shokoofeh Bahmani, Shirin Shojaei, Maryam Doostan, Amir Kiani, Roghayyeh Vakili-Ghartavol, Hassan Maleki


  • Open Access

    Exploring of therapeutic potential of indirubin-loaded nanofibrous scaffolds for localized melanoma treatment

    by Sajad Rahimi, Kamyar Khoshnevisan, Amir Hossein Izadi Nazar, Maryam Doostan, Hassan Maleki

    Nanofibrous scaffolds have been established as capable platforms for localized drug delivery systems of skin cancer management. Our study aimed to develop an electrospun nanofibrous scaffold loaded with indirubin, a naturally occurring bisindole alkaloid found in plants that bear indigo, for efficient targeted chemotherapy. The scaffold was prepared from polyvinyl alcohol (PVA) and chitosan (CS), using the electrospinning process, and incorporated with indirubin. Additional experiments were conducted to evaluate the physicochemical properties, perform antioxidant assays, and analyze the release profile. The scaffolds’ anticancer activity was evaluated on human skin melanoma cells. The prepared indirubin-loaded PVA/CS scaffold exhibited nanofibers (NFs) with a nanoscale diameter, a defect-free, and homogeneous morphology. Infrared spectroscopy confirmed the successful incorporation of indirubin into the scaffold. The scaffold displayed a hydrophilic surface, sufficient mechanical strength, high porosity, and a high liquid absorption capacity. In addition, the incorporation of 15 wt% indirubin demonstrated notable antioxidant properties, and its release from the NFs occurred in a controlled and extended manner over approximately 72 h. Furthermore, the scaffold significantly declined cell viability and induced apoptosis in melanoma cells. It is believed that an indirubin-loaded PVA/CS nanofibrous scaffold holds promise as a valuable system for localized melanoma treatment.


  • Open Access

    Advances in Drug Delivery Science for Diacerein: Strategies to Enhance Solubility, Bioavailability, and Pharmacokinetic Performance

    by Maryam Naseri, Sajjad Ghobakhlou, Niloofar Heidarizade, Mohammad Emad Akbari, Alireza Lotfabadi, Soroor Sadegh Malvajerd, Zhila Izadi, Hassan Maleki

    Diacerein is known as a disease-modifying anti-inflammatory drug, primarily used for the treatment of osteoarthritis. Despite its therapeutic potential, the clinical use of diacerein is hindered by poor aqueous solubility, low bioavailability, liver issues, and gastrointestinal side effects, particularly diarrhea. To address these limitations, various innovative pharmaceutical formulation approaches have been explored, including physical modifications, chemical complexation, nanotechnology-based drug delivery systems, and synergistic combination therapies. This review highlights progress in formulation approaches aimed at enhancing the solubility and therapeutic profile of diacerein. Special emphasis is placed on lipid-based carriers, vesicular systems, pH-responsive hydrogels, and dissolving microneedles. Together, these strategies provide a comprehensive platform for the rational design of diacerein formulations, offering promising avenues to overcome its clinical limitations and improve patient outcomes. The insights presented here may also guide the development of more effective delivery systems for other poorly soluble anti-inflammatory agents.


  • Biofabricated Hydrogel Composite of Tragacanth Gum and Chitosan Loaded With Copper Oxide Nanoparticles for Enhanced Cutaneous Wound Regeneration

    by Shahriar Hosseini, Maryam Doostan, Amir Hossein Izadi Nazar, Roghayyeh Vakili‐Ghartavol, Hassan Maleki

    Chronic wounds, often complicated by microbial growth and insufficient regeneration, pose a significant challenge. To address these issues, we developed a hydrogel dressing made from natural polymers, tragacanth gum (TG) and chitosan (CS), incorporated synthesized copper oxide nanoparticles (CuO NPs) to promote wound healing and inhibit microorganisms at the wound site. We synthesized CuO NPs using a reduction method with pomegranate peel extract and analyzed their characteristics. The TG/CS hydrogel was then prepared and loaded with the synthesized NPs, followed by relevant physicochemical analysis. The hydrogel's degradation rate and antibacterial activity were determined, and its effects on cell migration and viability in skin fibroblasts were evaluated using suitable methods. The synthesized CuO NPs showed nanometer dimensions (about 30–50 nm) with a consistent spherical morphology, and compositional analysis confirmed the presence of their constituent elements. The TG/CS hydrogel incorporating CuO NPs displayed a smooth and uniform appearance with a porous structure featuring interconnected micrometer‐sized pores. Infrared spectroscopy confirmed the functional groups of the hydrogel components and the presence of the NPs. Moreover, this hydrogel demonstrated high liquid absorption, porosity, and stable degradation over several days. It significantly inhibited the growth of both Gram‐positive and Gram‐negative bacteria. The hydrogel containing 10 wt% CuO NPs stimulated fibroblast cell growth and, most importantly, accelerated wound healing by inducing cell migration and filling the scratch gap within 48 h. Overall, the natural TG/CS hydrogel containing CuO NPs has a high potential to expedite wound healing as a multifunctional wound dressing.


  • Selenium nanoparticles and paclitaxel co-delivery by a PCL based nanofibrous scaffold to enhance melanoma therapy

    by Maryam Doostan, Ata’oLlah Rahmani Azar, Hassan Maleki

    The incidence of skin cancer has increased significantly in recent decades, highlighting the need for more effective treatments due to the limitations of traditional approaches. This study focused on creating a poly (ε-caprolactone) and chitosan (PCL/CS) nanofibrous scaffold loaded with selenium nanoparticles (Se NPs) and paclitaxel (PTX) to inhibit melanoma cell growth. The synthesized Se NPs, characterized by their uniform spherical shape and nano-scale size (∼120 nm), were incorporated into the scaffold. Then, the Se NPs and PTX were concurrently loaded into PCL/CS nanofibers at 5 wt%, which resulted in fibers with an average diameter of 253 ± 35 nm, presenting a ribbon-like morphology and absence of droplets/beads. The results indicated a high fluid absorption capacity, a wettability and high tensile strength of the produced scaffold. Moreover, the controlled release of the loaded compounds was provided over several days. Remarkably, high toxicity (>90%) and higher levels of apoptosis (>85%) were observed in A375 melanoma cells treated with the PTX-Se NPs PCL/CS scaffold. Moreover, the assessment of fibroblast growth and hemolysis confirmed the scaffold’s high level of biocompatibility. The PTX-Se NPs PCL/CS nanofibers exhibit favorable properties and strong anti-tumor efficacy, making them a promising scaffold for localized and selective chemotherapy in anti-melanoma treatment.


  • Enhanced healing of burn wounds by multifunctional alginate-chitosan hydrogel enclosing silymarin and zinc ‎oxide ‎nanoparticles

    by Moein Valadi, Maryam Doostan, Kamyar Khoshnevisan, Mahtab Doostan, Hassan Maleki


  • Accelerating healing of infected wounds with G. glabra extract and curcumin Co-loaded electrospun nanofibrous dressing

    by Maryam Doostan, Hassan Maleki, Kamyar Khoshnevisan, Hadi Baharifar, Mahtab Doostan, Sonia Bahrami

    This study aimed to construct a nanofibrous wound dressing composed of polyvinyl alcohol (PVA) and chitosan (CS) containing curcumin and Glycyrrhiza glabra root extract to inhibit infection and accelerate wound healing. Loading 10 wt% of G. glabra extract-curcumin (50:50) by electrospinng technique resulted in the formation of nanofibers (NFs) with diameter distribution 303 ± 38 and had a uniform and defect-free morphology. FTIR analysis confirmed the loading of the components without adverse interactions. Also, the results showed extremely high porosity, extraordinary liquid absorption capacity, and complete wettability. In addition, G. glabra extract-curcumin showed significant antioxidant activity and their release profile from NFs was continuous and sustained. Also, the prepared NF could inhibit the growth of both Gram-positive Saureus and Gram-negative E. coli strains. Wound healing evaluation in the infected animal model showed that the NFs caused full wound closure and accelerated skin regeneration. The studies on inhibiting the bacteria growth at the wound site also revealed complete inhibitory effects. Moreover, histopathology studies confirmed the complete regeneration of skin layers, formation of collagen fibers, and angiogenesis. Finally, PVA/CS NFs containing G. glabra extract-curcumin as a multifunctional bioactive wound dressing presented a promising approach for promoting the healing of infected wounds.


  • Evaluating the anti-neuropathic effects of naringin-loaded chitosan nanocarriers in a murine model of constriction injury

    by Maryam Safari, Sajad Fakhri, Hassan Maleki, Mohammad Hosein Farzaei

    Peripheral neuropathies are associated with various detrimental complications, leading to life-debilitating disorders, including neuropathic pain. Hence, the current study aimed to incorporate naringin, a potential natural component, into chitosan nanoparticles (NPs) to ameliorate the complications resulting from chronic constriction injury (CCI) induced painful neuropathy. The prepared NPs had a particle size of 220 nm and PDI = 0.37, with relatively spherical morphology and zeta potential of +41.5 mV. The relevant analyses indicated the loading and high encapsulation efficiency of naringin into the NPs as well as a prolonged release of naringin. The anti-neuropathic evaluations of chronic constriction injury (CCI)-induced rats treated with naringin-loaded NPs (10 mg/kg) remarkably ameliorated hyperalgesia and cold allodynia. In addition, the treatment with naringin-loaded NPs led to improvements in sensory and locomotor impairment, as evidenced by changes in behavioral parameters such as reduced paw licking, increased rearings, and enhanced crossings. The NPs treatment significantly attenuated the elevated levels of nitrite and restored the reduced glutathione level in the serum of CCI-induced rats. Moreover, histopathological analysis exhibited regeneration of the sciatic nerve injury through reducing myelin degeneration, axonal swelling, and nerve fiber derangement. Therefore, these findings suggest that the naringin-loaded chitosan NPs has promising pharmacological activities for the treatment of neuropathic pain sufferers.